Eligibility for PCSK-9 inhibitors treatment in acute coronary syndrome, chronic coronary artery disease and outpatient dyslipidemic patients-Reference-Cited by-同舟云学术

Eligibility for PCSK-9 inhibitors treatment in acute coronary syndrome, chronic coronary artery disease and outpatient dyslipidemic patients

Published:2020-06 Issue: Volume:303 Page:29-35
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Vlachopoulos Charalambos,Dima Ioanna,Soulis Dimitrios,Terentes-Printzios Dimitrios,Skoumas Ioannis,Aznaouridis Konstantinos,Solomou Eirini,Richter Dimitrios,Tousoulis Dimitrios

Funder

Amgen Hellas LTD, Greece

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel;Ference;Eur. Heart J.,2017

2. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials;Baigent;Lancet,2010

3. Ezetimibe added to statin therapy after acute coronary syndromes;Cannon;N. Engl. J. Med.,2015

4. Lipid-lowering agents for concurrent cardiovascular and chronic kidney disease;Katsiki;Expet Opin. Pharmacother.,2019

5. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society;Nordestgaard;Eur. Heart J.,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world data on treatment patterns in at least high cardiovascular risk patients on dual and triple lipid lowering therapy in a Hellenic nationwide e-prescription database;International Journal of Cardiology Cardiovascular Risk and Prevention;2024-06

2. Prognostic role of discordance between quantitative flow ratio and visual estimation in revascularization guidance;European Heart Journal Open;2023-12-26

3. LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments;International Journal of Cardiology;2021-12

4. Is it Time for Single-Pill Combinations in Dyslipidemia?;American Journal of Cardiovascular Drugs;2021-09-22